Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Astrid Schulze
Novel Methods for Assessing Oral Direct Factor Xa and Thrombin Inhibitors: Use of Point-Of-Care Testing and Urine Samples
Seminars in Thrombosis and Hemostasis
Cardiovascular Medicine
Hematology
Cardiology
Related publications
Antithrombin-Independent Thrombin Inhibitors, but Not Direct Factor Xa Inhibitors, Enhance Thrombin Generation in Plasma Through Inhibition of Thrombin-Thrombomodulin-Protein C System
Thrombosis and Haemostasis
Hematology
Engineered Factor Xa Variants Retain Procoagulant Activity Independent of Direct Factor Xa Inhibitors
Nature Communications
Astronomy
Genetics
Molecular Biology
Biochemistry
Chemistry
Physics
Rivaroxaban: An Oral Direct Inhibitor of Factor Xa
American Journal of Health-System Pharmacy
Medicine
Health Policy
Pharmacology
Pharmacy
The Pointy End of Point-Of-Care Testing for Direct Oral Anticoagulants
Thrombosis and Haemostasis
Hematology
Factor Xa Inhibitors
Discovery of a Novel, Potent, and Specific Family of Factor Xa Inhibitors via Combinatorial Chemistry
Biochemistry
Biochemistry
Effect of Famotidine on the Pharmacokinetics of Apixaban, an Oral Direct Factor Xa Inhibitor
Clinical Pharmacology: Advances and Applications
Pharmacology
Safety, Pharmacokinetics and Pharmacodynamics of Single Doses of Rivaroxaban – An Oral, Direct Factor Xa Inhibitor – In Elderly Chinese Subjects
Thrombosis and Haemostasis
Hematology
Antithrombotic Drug and Its Clinical Indication. Factor Xa Inhibitor. Oral Xa Inhibitor (DX-9065a).
Japanese Journal of Clinical Pharmacology and Therapeutics
Pharmacology
